WATCH LIVE
timothy sykes logo
AGL Stock Jumps As agilon Health Ramps Market Outreach Thumbnail
G Google News

AGL Stock Jumps As agilon Health Ramps Market Outreach

JACK KELLOGG•UPDATED JUN. 27, 2026, 10:09 AM ET
Reviewed by Ellis Hobbsand Fact-checked by Matt Monaco

agilon health inc. stocks have been trading up by 11.19 percent amid bullish sentiment on value-based care growth prospects

What Traders Need To Know

  • agilon health’s leadership will appear at two healthcare and digital health conferences, speaking on value-based care and meeting one-on-one with market participants.
  • Conference participation is aimed at boosting visibility for agilon health inc. and its ACO/value-based care model, not at updating financial guidance.
  • Multiple recent Form 4 filings show insider changes in AGL beneficial ownership, but give no detail on size, price, or whether shares were bought or sold.
  • Lack of transaction specifics means these AGL insider filings are noise for now, not clear bullish or bearish signals.

Candlestick Chart

Weekly Update Jun 22 – Jun 26, 2026: On Saturday, June 27, 2026 agilon health inc. stock [NYSE: AGL] is trending up by 11.19%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Healthcare industry expert:

Analyst sentiment – neutral

AGL (agilon health) remains an early‑scale value‑based primary care platform with strong top‑line momentum but weak underlying profitability. Revenue of ~$5.9B and 3–5‑year CAGR above 27% outpaces Healthcare Providers & Services peers, but negative EBIT margin (~‑6%) and ROE below ‑100% highlight an unsustainable economic model without continued mix and risk‑score improvement. Balance sheet leverage is modest (debt/equity 0.17, current ratio ~1.0), and recent positive free cash flow and Q1 profitability are encouraging but not yet durable.

Technically, AGL is in a short‑term uptrend, resolving a prior pullback with a sharp weekly reversal from 106.8 to 119.25. The 5‑minute tape shows buyers absorbing offers near 114 and driving a strong close, indicating improving liquidity and real money demand. Key actionable level is 114: above it, momentum longs can target 125 with tight risk; a decisive break back below 110 would negate the bullish setup and likely trigger fast mean reversion selling.

Conference participation and incremental investor outreach marginally improve visibility but are not thesis‑changing versus sector benchmarks that already favor scaled, profitable payor‑provider hybrids. Versus Healthcare and Providers & Services indices, AGL offers superior growth but materially inferior margins and return metrics, warranting a valuation discount until profitability stabilizes. I see balanced risk‑reward near current levels, with near‑term trading range defined by support at 114 and resistance around 130; only a sustained break above 130 would justify a more aggressive re‑rating.

More Breaking News

Quick Financial Overview

AGL has shown sharp near-term strength on the chart. Weekly data show price lifting from the low $100s to a recent close around $119, with the high of the week also near $119.25. The intraday range from roughly $104.40 to $119.25 in a single session signals strong momentum and elevated volatility. For short-term traders, that kind of wide range means clear opportunity but also real risk if entries and stops are sloppy.

From a fundamentals angle, agilon health inc. is a high-revenue, low-margin story. Revenue runs near $5.93B, but profitability ratios are deeply negative, with EBIT margin around -6.3% and profit margin above -6%. That tells you the core business model still burns through margin even at scale. Yet valuation on a sales basis looks lean, with price-to-sales about 0.08 and price-to-free-cash-flow near 5.2, showing the market is not paying a rich multiple for that revenue.

Balance sheet strength is mixed but not alarming. Debt levels look moderate, with total debt-to-equity around 0.17 and long-term debt-to-capital about 0.08, while the current ratio near 1.0 and quick ratio just under 1.0 suggest a tight but manageable liquidity position. Returns on equity and assets are sharply negative, reflecting ongoing profitability pressure despite quarterly net income near $48.9M in the latest report and positive free cash flow of about $20.6M. For traders, that combination paints AGL as a turnaround or execution story rather than a stable compounder.

Conclusion

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”